362 |
Optimal Planning of Revalving for Failing TAVR |
Nicolas Van Mieghem |
Apr. 19. 24 |
361 |
Imaging for Standard TAVI: CT Commissural Alignment and Coronary Access |
Didier Tchetche |
Apr. 19. 24 |
360 |
Bicuspid TAVR: All the Technical Issues and Data From Asan Medical Center |
Jung-Min Ahn |
Apr. 19. 24 |
359 |
Challenges With Valve-in-Valve TAVR - Role of Bioprosthetic Valve Fracture, Coronary Protection, and Leaflet Modification |
David Joel Cohen |
Apr. 19. 24 |
358 |
Valve Thrombosis and Valve Degeneration - How to Detect |
Yohei Ohno |
Apr. 19. 24 |
357 |
The UPSTREAM Management of Aortic Stenosis |
Alan C. Yeung |
Apr. 19. 24 |
356 |
Current Status of Valvular and Structural Heart Disease Intervention in Japan: New Insights from the OCEAN-SHD Family |
Kentaro Hayashida |
Apr. 19. 24 |
355 |
Moderate AS in HFrEF: Time-to-Treat is Now and Future Expectation from RCTs |
Nicolas Van Mieghem |
Apr. 19. 24 |
354 |
TAVR-in-TAVR: Planning and Optimizing the Procedure |
Karl Poon |
Apr. 19. 24 |
353 |
Ultra-Minimalist TAVR: Novel Strategy for a Quick Procedure and Short Hospital Stay |
James Flaherty |
Apr. 19. 24 |